Cornell Pochily Investment Advisors Inc. Sells 75 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cornell Pochily Investment Advisors Inc. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,165 shares of the medical equipment provider’s stock after selling 75 shares during the quarter. Cornell Pochily Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $608,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter worth about $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,453 shares of company stock worth $22,059,506. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ISRG shares. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday. One research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Stock Down 4.0 %

Intuitive Surgical stock opened at $584.05 on Monday. The business’s 50-day simple moving average is $547.16 and its 200 day simple moving average is $505.21. The stock has a market cap of $208.03 billion, a price-to-earnings ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.